Catalyst Wire Dossier Catalyst Wire Dossier

FE 201836

· Ferring Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FE 201836, covering 2020-12-23 to 2020-12-23. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults [Phase 2]

See pricing